nodes	percent_of_prediction	percent_of_DWPC	metapath
Morphine—ABCB1—peripheral nervous system neoplasm	0.31	1	CbGaD
Morphine—UGT2B7—Epirubicin—peripheral nervous system neoplasm	0.0958	0.224	CbGbCtD
Morphine—UGT1A1—Etoposide—peripheral nervous system neoplasm	0.0645	0.151	CbGbCtD
Morphine—CYP2C8—Tretinoin—peripheral nervous system neoplasm	0.0449	0.105	CbGbCtD
Morphine—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.0327	0.0764	CbGbCtD
Morphine—ABCB1—Topotecan—peripheral nervous system neoplasm	0.0327	0.0764	CbGbCtD
Morphine—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.0227	0.053	CbGbCtD
Morphine—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0196	0.0458	CbGbCtD
Morphine—CYP2C8—Etoposide—peripheral nervous system neoplasm	0.0189	0.0442	CbGbCtD
Morphine—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0182	0.0426	CbGbCtD
Morphine—ABCB1—Vincristine—peripheral nervous system neoplasm	0.014	0.0326	CbGbCtD
Morphine—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.013	0.0304	CbGbCtD
Morphine—ABCB1—Etoposide—peripheral nervous system neoplasm	0.0128	0.0299	CbGbCtD
Morphine—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.00872	0.0204	CbGbCtD
Morphine—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.00836	0.0195	CbGbCtD
Morphine—CYP2D6—Doxorubicin—peripheral nervous system neoplasm	0.00822	0.0192	CbGbCtD
Morphine—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.00766	0.0179	CbGbCtD
Morphine—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00523	0.0122	CbGbCtD
Morphine—Galantamine—BCHE—peripheral nervous system neoplasm	0.000802	0.505	CrCbGaD
Morphine—Naltrexone—ABCB1—peripheral nervous system neoplasm	0.000455	0.286	CrCbGaD
Morphine—Naloxone—ABCB1—peripheral nervous system neoplasm	0.000332	0.209	CrCbGaD
Morphine—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000109	0.000444	CcSEcCtD
Morphine—Orthostatic hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000109	0.000442	CcSEcCtD
Morphine—Abdominal pain upper—Doxorubicin—peripheral nervous system neoplasm	0.000109	0.000442	CcSEcCtD
Morphine—Hypokalaemia—Doxorubicin—peripheral nervous system neoplasm	0.000109	0.000441	CcSEcCtD
Morphine—Breast disorder—Doxorubicin—peripheral nervous system neoplasm	0.000108	0.000438	CcSEcCtD
Morphine—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000108	0.000437	CcSEcCtD
Morphine—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000107	0.000435	CcSEcCtD
Morphine—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000107	0.000434	CcSEcCtD
Morphine—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000107	0.000433	CcSEcCtD
Morphine—Nasopharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000107	0.000433	CcSEcCtD
Morphine—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000106	0.000432	CcSEcCtD
Morphine—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000106	0.000429	CcSEcCtD
Morphine—Pain—Cisplatin—peripheral nervous system neoplasm	0.000105	0.000428	CcSEcCtD
Morphine—Dysuria—Epirubicin—peripheral nervous system neoplasm	0.000104	0.000423	CcSEcCtD
Morphine—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000104	0.000422	CcSEcCtD
Morphine—Abdominal distension—Doxorubicin—peripheral nervous system neoplasm	0.000104	0.000421	CcSEcCtD
Morphine—Influenza—Doxorubicin—peripheral nervous system neoplasm	0.000103	0.000419	CcSEcCtD
Morphine—Dysphagia—Doxorubicin—peripheral nervous system neoplasm	0.000103	0.000419	CcSEcCtD
Morphine—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000103	0.000417	CcSEcCtD
Morphine—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000102	0.000416	CcSEcCtD
Morphine—Eosinophilia—Doxorubicin—peripheral nervous system neoplasm	0.000102	0.000414	CcSEcCtD
Morphine—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000102	0.000413	CcSEcCtD
Morphine—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000101	0.000412	CcSEcCtD
Morphine—Weight decreased—Epirubicin—peripheral nervous system neoplasm	0.000101	0.000409	CcSEcCtD
Morphine—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000101	0.000409	CcSEcCtD
Morphine—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	0.0001	0.000408	CcSEcCtD
Morphine—Somnolence—Etoposide—peripheral nervous system neoplasm	0.0001	0.000408	CcSEcCtD
Morphine—Asthenia—Vincristine—peripheral nervous system neoplasm	0.0001	0.000406	CcSEcCtD
Morphine—Drowsiness—Epirubicin—peripheral nervous system neoplasm	9.93e-05	0.000403	CcSEcCtD
Morphine—Vomiting—Dactinomycin—peripheral nervous system neoplasm	9.92e-05	0.000403	CcSEcCtD
Morphine—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	9.9e-05	0.000402	CcSEcCtD
Morphine—Rash—Dactinomycin—peripheral nervous system neoplasm	9.84e-05	0.0004	CcSEcCtD
Morphine—Decreased appetite—Etoposide—peripheral nervous system neoplasm	9.82e-05	0.000399	CcSEcCtD
Morphine—Renal failure—Epirubicin—peripheral nervous system neoplasm	9.76e-05	0.000396	CcSEcCtD
Morphine—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	9.75e-05	0.000396	CcSEcCtD
Morphine—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	9.75e-05	0.000396	CcSEcCtD
Morphine—Fatigue—Etoposide—peripheral nervous system neoplasm	9.74e-05	0.000396	CcSEcCtD
Morphine—Stomatitis—Epirubicin—peripheral nervous system neoplasm	9.68e-05	0.000393	CcSEcCtD
Morphine—Constipation—Etoposide—peripheral nervous system neoplasm	9.66e-05	0.000392	CcSEcCtD
Morphine—Pain—Etoposide—peripheral nervous system neoplasm	9.66e-05	0.000392	CcSEcCtD
Morphine—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	9.65e-05	0.000392	CcSEcCtD
Morphine—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	9.65e-05	0.000392	CcSEcCtD
Morphine—Dysuria—Doxorubicin—peripheral nervous system neoplasm	9.64e-05	0.000391	CcSEcCtD
Morphine—Dizziness—Alitretinoin—peripheral nervous system neoplasm	9.57e-05	0.000389	CcSEcCtD
Morphine—Diarrhoea—Vincristine—peripheral nervous system neoplasm	9.54e-05	0.000388	CcSEcCtD
Morphine—Sweating—Epirubicin—peripheral nervous system neoplasm	9.52e-05	0.000387	CcSEcCtD
Morphine—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	9.39e-05	0.000381	CcSEcCtD
Morphine—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	9.32e-05	0.000379	CcSEcCtD
Morphine—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	9.31e-05	0.000378	CcSEcCtD
Morphine—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	9.29e-05	0.000378	CcSEcCtD
Morphine—Nausea—Dactinomycin—peripheral nervous system neoplasm	9.27e-05	0.000377	CcSEcCtD
Morphine—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	9.24e-05	0.000375	CcSEcCtD
Morphine—Dizziness—Vincristine—peripheral nervous system neoplasm	9.22e-05	0.000375	CcSEcCtD
Morphine—Vomiting—Alitretinoin—peripheral nervous system neoplasm	9.2e-05	0.000374	CcSEcCtD
Morphine—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	9.19e-05	0.000373	CcSEcCtD
Morphine—Rash—Alitretinoin—peripheral nervous system neoplasm	9.13e-05	0.000371	CcSEcCtD
Morphine—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	9.12e-05	0.00037	CcSEcCtD
Morphine—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	9.09e-05	0.000369	CcSEcCtD
Morphine—Bradycardia—Epirubicin—peripheral nervous system neoplasm	9.07e-05	0.000369	CcSEcCtD
Morphine—Headache—Alitretinoin—peripheral nervous system neoplasm	9.07e-05	0.000368	CcSEcCtD
Morphine—Renal failure—Doxorubicin—peripheral nervous system neoplasm	9.03e-05	0.000367	CcSEcCtD
Morphine—Urticaria—Etoposide—peripheral nervous system neoplasm	8.97e-05	0.000365	CcSEcCtD
Morphine—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	8.96e-05	0.000364	CcSEcCtD
Morphine—Rhinitis—Epirubicin—peripheral nervous system neoplasm	8.94e-05	0.000363	CcSEcCtD
Morphine—Abdominal pain—Etoposide—peripheral nervous system neoplasm	8.93e-05	0.000363	CcSEcCtD
Morphine—Body temperature increased—Etoposide—peripheral nervous system neoplasm	8.93e-05	0.000363	CcSEcCtD
Morphine—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	8.93e-05	0.000363	CcSEcCtD
Morphine—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	8.93e-05	0.000363	CcSEcCtD
Morphine—Hepatitis—Epirubicin—peripheral nervous system neoplasm	8.91e-05	0.000362	CcSEcCtD
Morphine—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	8.87e-05	0.00036	CcSEcCtD
Morphine—Vomiting—Vincristine—peripheral nervous system neoplasm	8.87e-05	0.00036	CcSEcCtD
Morphine—Asthenia—Cisplatin—peripheral nervous system neoplasm	8.85e-05	0.000359	CcSEcCtD
Morphine—Sweating—Doxorubicin—peripheral nervous system neoplasm	8.81e-05	0.000358	CcSEcCtD
Morphine—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	8.8e-05	0.000358	CcSEcCtD
Morphine—Rash—Vincristine—peripheral nervous system neoplasm	8.79e-05	0.000357	CcSEcCtD
Morphine—Dermatitis—Vincristine—peripheral nervous system neoplasm	8.79e-05	0.000357	CcSEcCtD
Morphine—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	8.78e-05	0.000357	CcSEcCtD
Morphine—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	8.76e-05	0.000356	CcSEcCtD
Morphine—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	8.74e-05	0.000355	CcSEcCtD
Morphine—Headache—Vincristine—peripheral nervous system neoplasm	8.74e-05	0.000355	CcSEcCtD
Morphine—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	8.69e-05	0.000353	CcSEcCtD
Morphine—Nausea—Alitretinoin—peripheral nervous system neoplasm	8.6e-05	0.000349	CcSEcCtD
Morphine—Visual impairment—Epirubicin—peripheral nervous system neoplasm	8.59e-05	0.000349	CcSEcCtD
Morphine—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	8.44e-05	0.000343	CcSEcCtD
Morphine—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	8.4e-05	0.000341	CcSEcCtD
Morphine—Eye disorder—Epirubicin—peripheral nervous system neoplasm	8.33e-05	0.000338	CcSEcCtD
Morphine—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	8.32e-05	0.000338	CcSEcCtD
Morphine—Nausea—Vincristine—peripheral nervous system neoplasm	8.28e-05	0.000336	CcSEcCtD
Morphine—Flushing—Epirubicin—peripheral nervous system neoplasm	8.27e-05	0.000336	CcSEcCtD
Morphine—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	8.27e-05	0.000336	CcSEcCtD
Morphine—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	8.25e-05	0.000335	CcSEcCtD
Morphine—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	8.21e-05	0.000333	CcSEcCtD
Morphine—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	8.15e-05	0.000331	CcSEcCtD
Morphine—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	8.12e-05	0.00033	CcSEcCtD
Morphine—Asthenia—Etoposide—peripheral nervous system neoplasm	8.11e-05	0.000329	CcSEcCtD
Morphine—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	8.1e-05	0.000329	CcSEcCtD
Morphine—Angiopathy—Epirubicin—peripheral nervous system neoplasm	8.09e-05	0.000329	CcSEcCtD
Morphine—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	8.08e-05	0.000328	CcSEcCtD
Morphine—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	8.03e-05	0.000326	CcSEcCtD
Morphine—Chills—Epirubicin—peripheral nervous system neoplasm	8e-05	0.000325	CcSEcCtD
Morphine—Pruritus—Etoposide—peripheral nervous system neoplasm	7.99e-05	0.000325	CcSEcCtD
Morphine—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	7.95e-05	0.000323	CcSEcCtD
Morphine—Vomiting—Cisplatin—peripheral nervous system neoplasm	7.84e-05	0.000318	CcSEcCtD
Morphine—Mental disorder—Epirubicin—peripheral nervous system neoplasm	7.81e-05	0.000317	CcSEcCtD
Morphine—Rash—Cisplatin—peripheral nervous system neoplasm	7.78e-05	0.000316	CcSEcCtD
Morphine—Dermatitis—Cisplatin—peripheral nervous system neoplasm	7.77e-05	0.000316	CcSEcCtD
Morphine—Malnutrition—Epirubicin—peripheral nervous system neoplasm	7.76e-05	0.000315	CcSEcCtD
Morphine—Erythema—Epirubicin—peripheral nervous system neoplasm	7.76e-05	0.000315	CcSEcCtD
Morphine—Diarrhoea—Etoposide—peripheral nervous system neoplasm	7.73e-05	0.000314	CcSEcCtD
Morphine—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	7.71e-05	0.000313	CcSEcCtD
Morphine—Flushing—Doxorubicin—peripheral nervous system neoplasm	7.65e-05	0.000311	CcSEcCtD
Morphine—Flatulence—Epirubicin—peripheral nervous system neoplasm	7.65e-05	0.000311	CcSEcCtD
Morphine—Tension—Epirubicin—peripheral nervous system neoplasm	7.61e-05	0.000309	CcSEcCtD
Morphine—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	7.6e-05	0.000309	CcSEcCtD
Morphine—Nervousness—Epirubicin—peripheral nervous system neoplasm	7.54e-05	0.000306	CcSEcCtD
Morphine—Back pain—Epirubicin—peripheral nervous system neoplasm	7.51e-05	0.000305	CcSEcCtD
Morphine—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	7.48e-05	0.000304	CcSEcCtD
Morphine—Dizziness—Etoposide—peripheral nervous system neoplasm	7.47e-05	0.000303	CcSEcCtD
Morphine—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	7.46e-05	0.000303	CcSEcCtD
Morphine—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	7.43e-05	0.000302	CcSEcCtD
Morphine—Chills—Doxorubicin—peripheral nervous system neoplasm	7.4e-05	0.000301	CcSEcCtD
Morphine—Nausea—Cisplatin—peripheral nervous system neoplasm	7.32e-05	0.000298	CcSEcCtD
Morphine—Vision blurred—Epirubicin—peripheral nervous system neoplasm	7.31e-05	0.000297	CcSEcCtD
Morphine—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	7.23e-05	0.000294	CcSEcCtD
Morphine—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	7.2e-05	0.000292	CcSEcCtD
Morphine—Vomiting—Etoposide—peripheral nervous system neoplasm	7.18e-05	0.000292	CcSEcCtD
Morphine—Erythema—Doxorubicin—peripheral nervous system neoplasm	7.18e-05	0.000292	CcSEcCtD
Morphine—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	7.18e-05	0.000292	CcSEcCtD
Morphine—Anaemia—Epirubicin—peripheral nervous system neoplasm	7.17e-05	0.000291	CcSEcCtD
Morphine—Agitation—Epirubicin—peripheral nervous system neoplasm	7.13e-05	0.00029	CcSEcCtD
Morphine—Rash—Etoposide—peripheral nervous system neoplasm	7.12e-05	0.000289	CcSEcCtD
Morphine—Dermatitis—Etoposide—peripheral nervous system neoplasm	7.12e-05	0.000289	CcSEcCtD
Morphine—Headache—Etoposide—peripheral nervous system neoplasm	7.08e-05	0.000287	CcSEcCtD
Morphine—Flatulence—Doxorubicin—peripheral nervous system neoplasm	7.07e-05	0.000287	CcSEcCtD
Morphine—Tension—Doxorubicin—peripheral nervous system neoplasm	7.05e-05	0.000286	CcSEcCtD
Morphine—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	7.03e-05	0.000286	CcSEcCtD
Morphine—Malaise—Epirubicin—peripheral nervous system neoplasm	7e-05	0.000284	CcSEcCtD
Morphine—Nervousness—Doxorubicin—peripheral nervous system neoplasm	6.97e-05	0.000283	CcSEcCtD
Morphine—Vertigo—Epirubicin—peripheral nervous system neoplasm	6.97e-05	0.000283	CcSEcCtD
Morphine—Syncope—Epirubicin—peripheral nervous system neoplasm	6.96e-05	0.000283	CcSEcCtD
Morphine—Leukopenia—Epirubicin—peripheral nervous system neoplasm	6.95e-05	0.000282	CcSEcCtD
Morphine—Back pain—Doxorubicin—peripheral nervous system neoplasm	6.94e-05	0.000282	CcSEcCtD
Morphine—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	6.9e-05	0.00028	CcSEcCtD
Morphine—Palpitations—Epirubicin—peripheral nervous system neoplasm	6.86e-05	0.000279	CcSEcCtD
Morphine—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	6.82e-05	0.000277	CcSEcCtD
Morphine—Cough—Epirubicin—peripheral nervous system neoplasm	6.77e-05	0.000275	CcSEcCtD
Morphine—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	6.77e-05	0.000275	CcSEcCtD
Morphine—Convulsion—Epirubicin—peripheral nervous system neoplasm	6.72e-05	0.000273	CcSEcCtD
Morphine—Nausea—Etoposide—peripheral nervous system neoplasm	6.71e-05	0.000273	CcSEcCtD
Morphine—Hypertension—Epirubicin—peripheral nervous system neoplasm	6.7e-05	0.000272	CcSEcCtD
Morphine—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	6.66e-05	0.000271	CcSEcCtD
Morphine—Anaemia—Doxorubicin—peripheral nervous system neoplasm	6.64e-05	0.00027	CcSEcCtD
Morphine—Arthralgia—Epirubicin—peripheral nervous system neoplasm	6.61e-05	0.000268	CcSEcCtD
Morphine—Chest pain—Epirubicin—peripheral nervous system neoplasm	6.61e-05	0.000268	CcSEcCtD
Morphine—Agitation—Doxorubicin—peripheral nervous system neoplasm	6.6e-05	0.000268	CcSEcCtD
Morphine—Anxiety—Epirubicin—peripheral nervous system neoplasm	6.58e-05	0.000267	CcSEcCtD
Morphine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	6.56e-05	0.000266	CcSEcCtD
Morphine—Discomfort—Epirubicin—peripheral nervous system neoplasm	6.53e-05	0.000265	CcSEcCtD
Morphine—Malaise—Doxorubicin—peripheral nervous system neoplasm	6.47e-05	0.000263	CcSEcCtD
Morphine—Dry mouth—Epirubicin—peripheral nervous system neoplasm	6.46e-05	0.000262	CcSEcCtD
Morphine—Vertigo—Doxorubicin—peripheral nervous system neoplasm	6.45e-05	0.000262	CcSEcCtD
Morphine—Syncope—Doxorubicin—peripheral nervous system neoplasm	6.44e-05	0.000262	CcSEcCtD
Morphine—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	6.43e-05	0.000261	CcSEcCtD
Morphine—Confusional state—Epirubicin—peripheral nervous system neoplasm	6.39e-05	0.000259	CcSEcCtD
Morphine—Palpitations—Doxorubicin—peripheral nervous system neoplasm	6.34e-05	0.000258	CcSEcCtD
Morphine—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	6.33e-05	0.000257	CcSEcCtD
Morphine—Oedema—Epirubicin—peripheral nervous system neoplasm	6.33e-05	0.000257	CcSEcCtD
Morphine—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	6.31e-05	0.000256	CcSEcCtD
Morphine—Infection—Epirubicin—peripheral nervous system neoplasm	6.29e-05	0.000256	CcSEcCtD
Morphine—Cough—Doxorubicin—peripheral nervous system neoplasm	6.27e-05	0.000254	CcSEcCtD
Morphine—Shock—Epirubicin—peripheral nervous system neoplasm	6.23e-05	0.000253	CcSEcCtD
Morphine—Convulsion—Doxorubicin—peripheral nervous system neoplasm	6.22e-05	0.000253	CcSEcCtD
Morphine—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	6.21e-05	0.000252	CcSEcCtD
Morphine—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	6.2e-05	0.000252	CcSEcCtD
Morphine—Hypertension—Doxorubicin—peripheral nervous system neoplasm	6.2e-05	0.000252	CcSEcCtD
Morphine—Tachycardia—Epirubicin—peripheral nervous system neoplasm	6.18e-05	0.000251	CcSEcCtD
Morphine—Skin disorder—Epirubicin—peripheral nervous system neoplasm	6.15e-05	0.00025	CcSEcCtD
Morphine—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	6.12e-05	0.000249	CcSEcCtD
Morphine—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	6.11e-05	0.000248	CcSEcCtD
Morphine—Chest pain—Doxorubicin—peripheral nervous system neoplasm	6.11e-05	0.000248	CcSEcCtD
Morphine—Anxiety—Doxorubicin—peripheral nervous system neoplasm	6.09e-05	0.000247	CcSEcCtD
Morphine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	6.07e-05	0.000247	CcSEcCtD
Morphine—Discomfort—Doxorubicin—peripheral nervous system neoplasm	6.04e-05	0.000245	CcSEcCtD
Morphine—Anorexia—Epirubicin—peripheral nervous system neoplasm	6.04e-05	0.000245	CcSEcCtD
Morphine—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	5.98e-05	0.000243	CcSEcCtD
Morphine—Hypotension—Epirubicin—peripheral nervous system neoplasm	5.92e-05	0.00024	CcSEcCtD
Morphine—Confusional state—Doxorubicin—peripheral nervous system neoplasm	5.91e-05	0.00024	CcSEcCtD
Morphine—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	5.86e-05	0.000238	CcSEcCtD
Morphine—Oedema—Doxorubicin—peripheral nervous system neoplasm	5.86e-05	0.000238	CcSEcCtD
Morphine—Infection—Doxorubicin—peripheral nervous system neoplasm	5.82e-05	0.000236	CcSEcCtD
Morphine—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	5.77e-05	0.000234	CcSEcCtD
Morphine—Shock—Doxorubicin—peripheral nervous system neoplasm	5.76e-05	0.000234	CcSEcCtD
Morphine—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	5.75e-05	0.000233	CcSEcCtD
Morphine—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	5.74e-05	0.000233	CcSEcCtD
Morphine—Insomnia—Epirubicin—peripheral nervous system neoplasm	5.73e-05	0.000233	CcSEcCtD
Morphine—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	5.72e-05	0.000232	CcSEcCtD
Morphine—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	5.69e-05	0.000231	CcSEcCtD
Morphine—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	5.69e-05	0.000231	CcSEcCtD
Morphine—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	5.66e-05	0.00023	CcSEcCtD
Morphine—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	5.65e-05	0.000229	CcSEcCtD
Morphine—Somnolence—Epirubicin—peripheral nervous system neoplasm	5.63e-05	0.000229	CcSEcCtD
Morphine—Anorexia—Doxorubicin—peripheral nervous system neoplasm	5.59e-05	0.000227	CcSEcCtD
Morphine—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	5.57e-05	0.000226	CcSEcCtD
Morphine—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	5.51e-05	0.000224	CcSEcCtD
Morphine—Hypotension—Doxorubicin—peripheral nervous system neoplasm	5.48e-05	0.000222	CcSEcCtD
Morphine—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	5.47e-05	0.000222	CcSEcCtD
Morphine—Fatigue—Epirubicin—peripheral nervous system neoplasm	5.46e-05	0.000222	CcSEcCtD
Morphine—Pain—Epirubicin—peripheral nervous system neoplasm	5.42e-05	0.00022	CcSEcCtD
Morphine—Constipation—Epirubicin—peripheral nervous system neoplasm	5.42e-05	0.00022	CcSEcCtD
Morphine—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	5.34e-05	0.000217	CcSEcCtD
Morphine—Insomnia—Doxorubicin—peripheral nervous system neoplasm	5.3e-05	0.000215	CcSEcCtD
Morphine—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	5.26e-05	0.000214	CcSEcCtD
Morphine—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	5.22e-05	0.000212	CcSEcCtD
Morphine—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	5.22e-05	0.000212	CcSEcCtD
Morphine—Somnolence—Doxorubicin—peripheral nervous system neoplasm	5.21e-05	0.000212	CcSEcCtD
Morphine—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	5.18e-05	0.00021	CcSEcCtD
Morphine—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	5.16e-05	0.00021	CcSEcCtD
Morphine—OPRL1—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	5.13e-05	0.00347	CbGpPWpGaD
Morphine—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	5.09e-05	0.000207	CcSEcCtD
Morphine—OPRD1—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	5.09e-05	0.00344	CbGpPWpGaD
Morphine—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	5.06e-05	0.000205	CcSEcCtD
Morphine—Fatigue—Doxorubicin—peripheral nervous system neoplasm	5.05e-05	0.000205	CcSEcCtD
Morphine—Urticaria—Epirubicin—peripheral nervous system neoplasm	5.03e-05	0.000204	CcSEcCtD
Morphine—Constipation—Doxorubicin—peripheral nervous system neoplasm	5.01e-05	0.000204	CcSEcCtD
Morphine—Pain—Doxorubicin—peripheral nervous system neoplasm	5.01e-05	0.000204	CcSEcCtD
Morphine—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	5.01e-05	0.000203	CcSEcCtD
Morphine—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	5.01e-05	0.000203	CcSEcCtD
Morphine—OPRK1—G alpha (i) signalling events—GNAS—peripheral nervous system neoplasm	4.91e-05	0.00332	CbGpPWpGaD
Morphine—OPRD1—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	4.88e-05	0.0033	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	4.86e-05	0.00328	CbGpPWpGaD
Morphine—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	4.83e-05	0.000196	CcSEcCtD
Morphine—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	4.79e-05	0.000195	CcSEcCtD
Morphine—OPRL1—Circadian rythm related genes—TP53—peripheral nervous system neoplasm	4.75e-05	0.00321	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—HSD17B12—peripheral nervous system neoplasm	4.75e-05	0.00321	CbGpPWpGaD
Morphine—OPRM1—G alpha (i) signalling events—KNG1—peripheral nervous system neoplasm	4.75e-05	0.00321	CbGpPWpGaD
Morphine—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	4.67e-05	0.00019	CcSEcCtD
Morphine—OPRL1—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	4.66e-05	0.00315	CbGpPWpGaD
Morphine—Urticaria—Doxorubicin—peripheral nervous system neoplasm	4.65e-05	0.000189	CcSEcCtD
Morphine—OPRL1—Signaling Pathways—VIP—peripheral nervous system neoplasm	4.64e-05	0.00314	CbGpPWpGaD
Morphine—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	4.63e-05	0.000188	CcSEcCtD
Morphine—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	4.63e-05	0.000188	CcSEcCtD
Morphine—Asthenia—Epirubicin—peripheral nervous system neoplasm	4.54e-05	0.000185	CcSEcCtD
Morphine—OPRL1—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	4.49e-05	0.00303	CbGpPWpGaD
Morphine—Pruritus—Epirubicin—peripheral nervous system neoplasm	4.48e-05	0.000182	CcSEcCtD
Morphine—OPRK1—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	4.46e-05	0.00302	CbGpPWpGaD
Morphine—UGT1A8—Metabolism—ENO2—peripheral nervous system neoplasm	4.44e-05	0.003	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—NTS—peripheral nervous system neoplasm	4.43e-05	0.00299	CbGpPWpGaD
Morphine—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	4.33e-05	0.000176	CcSEcCtD
Morphine—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	4.32e-05	0.000175	CcSEcCtD
Morphine—OPRL1—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	4.29e-05	0.0029	CbGpPWpGaD
Morphine—OPRK1—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	4.28e-05	0.00289	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—CD55—peripheral nervous system neoplasm	4.25e-05	0.00287	CbGpPWpGaD
Morphine—Asthenia—Doxorubicin—peripheral nervous system neoplasm	4.2e-05	0.000171	CcSEcCtD
Morphine—Dizziness—Epirubicin—peripheral nervous system neoplasm	4.19e-05	0.00017	CcSEcCtD
Morphine—OPRM1—G alpha (i) signalling events—GNAS—peripheral nervous system neoplasm	4.15e-05	0.0028	CbGpPWpGaD
Morphine—Pruritus—Doxorubicin—peripheral nervous system neoplasm	4.15e-05	0.000168	CcSEcCtD
Morphine—OPRL1—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	4.08e-05	0.00275	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—HSD17B12—peripheral nervous system neoplasm	4.04e-05	0.00273	CbGpPWpGaD
Morphine—Vomiting—Epirubicin—peripheral nervous system neoplasm	4.03e-05	0.000164	CcSEcCtD
Morphine—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	4.01e-05	0.000163	CcSEcCtD
Morphine—Rash—Epirubicin—peripheral nervous system neoplasm	3.99e-05	0.000162	CcSEcCtD
Morphine—Dermatitis—Epirubicin—peripheral nervous system neoplasm	3.99e-05	0.000162	CcSEcCtD
Morphine—Headache—Epirubicin—peripheral nervous system neoplasm	3.97e-05	0.000161	CcSEcCtD
Morphine—OPRK1—Signaling by GPCR—NTS—peripheral nervous system neoplasm	3.88e-05	0.00262	CbGpPWpGaD
Morphine—UGT2B15—Metabolism—ENO2—peripheral nervous system neoplasm	3.88e-05	0.00262	CbGpPWpGaD
Morphine—UGT2B4—Metabolism—ENO2—peripheral nervous system neoplasm	3.88e-05	0.00262	CbGpPWpGaD
Morphine—CYP2C8—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	3.88e-05	0.00262	CbGpPWpGaD
Morphine—OPRD1—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	3.88e-05	0.00262	CbGpPWpGaD
Morphine—Dizziness—Doxorubicin—peripheral nervous system neoplasm	3.87e-05	0.000157	CcSEcCtD
Morphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	3.77e-05	0.00255	CbGpPWpGaD
Morphine—Nausea—Epirubicin—peripheral nervous system neoplasm	3.76e-05	0.000153	CcSEcCtD
Morphine—UGT1A8—Metabolism—BCHE—peripheral nervous system neoplasm	3.75e-05	0.00254	CbGpPWpGaD
Morphine—Vomiting—Doxorubicin—peripheral nervous system neoplasm	3.73e-05	0.000151	CcSEcCtD
Morphine—OPRK1—Signaling by GPCR—CD55—peripheral nervous system neoplasm	3.72e-05	0.00252	CbGpPWpGaD
Morphine—OPRD1—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	3.7e-05	0.0025	CbGpPWpGaD
Morphine—Rash—Doxorubicin—peripheral nervous system neoplasm	3.69e-05	0.00015	CcSEcCtD
Morphine—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	3.69e-05	0.00015	CcSEcCtD
Morphine—Headache—Doxorubicin—peripheral nervous system neoplasm	3.67e-05	0.000149	CcSEcCtD
Morphine—OPRM1—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	3.61e-05	0.00244	CbGpPWpGaD
Morphine—UGT1A8—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.58e-05	0.00242	CbGpPWpGaD
Morphine—UGT1A8—Metabolism—TH—peripheral nervous system neoplasm	3.53e-05	0.00238	CbGpPWpGaD
Morphine—Nausea—Doxorubicin—peripheral nervous system neoplasm	3.48e-05	0.000141	CcSEcCtD
Morphine—UGT1A3—Metabolism—GNS—peripheral nervous system neoplasm	3.43e-05	0.00232	CbGpPWpGaD
Morphine—OPRK1—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	3.4e-05	0.0023	CbGpPWpGaD
Morphine—OPRD1—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	3.39e-05	0.00229	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—VIP—peripheral nervous system neoplasm	3.36e-05	0.00227	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—NME1—peripheral nervous system neoplasm	3.29e-05	0.00222	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—NTS—peripheral nervous system neoplasm	3.28e-05	0.00222	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—HSD17B12—peripheral nervous system neoplasm	3.28e-05	0.00222	CbGpPWpGaD
Morphine—UGT2B15—Metabolism—BCHE—peripheral nervous system neoplasm	3.28e-05	0.00222	CbGpPWpGaD
Morphine—UGT2B4—Metabolism—BCHE—peripheral nervous system neoplasm	3.28e-05	0.00222	CbGpPWpGaD
Morphine—OPRM1—IL4-mediated signaling events—AKT1—peripheral nervous system neoplasm	3.25e-05	0.0022	CbGpPWpGaD
Morphine—OPRK1—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	3.24e-05	0.00219	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	3.22e-05	0.00218	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—COX2—peripheral nervous system neoplasm	3.17e-05	0.00214	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—CD55—peripheral nervous system neoplasm	3.15e-05	0.00213	CbGpPWpGaD
Morphine—UGT2B4—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.13e-05	0.00211	CbGpPWpGaD
Morphine—UGT2B15—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.13e-05	0.00211	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	3.1e-05	0.00209	CbGpPWpGaD
Morphine—UGT2B15—Metabolism—TH—peripheral nervous system neoplasm	3.08e-05	0.00208	CbGpPWpGaD
Morphine—UGT2B4—Metabolism—TH—peripheral nervous system neoplasm	3.08e-05	0.00208	CbGpPWpGaD
Morphine—OPRK1—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	2.97e-05	0.00201	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—VIP—peripheral nervous system neoplasm	2.94e-05	0.00199	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—GNS—peripheral nervous system neoplasm	2.92e-05	0.00197	CbGpPWpGaD
Morphine—UGT1A8—Metabolism—GNAS—peripheral nervous system neoplasm	2.88e-05	0.00195	CbGpPWpGaD
Morphine—OPRM1—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	2.87e-05	0.00194	CbGpPWpGaD
Morphine—OPRL1—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	2.83e-05	0.00191	CbGpPWpGaD
Morphine—UGT1A8—Metabolism—ABCB1—peripheral nervous system neoplasm	2.83e-05	0.00191	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—NME1—peripheral nervous system neoplasm	2.8e-05	0.00189	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—KNG1—peripheral nervous system neoplasm	2.75e-05	0.00186	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—peripheral nervous system neoplasm	2.75e-05	0.00186	CbGpPWpGaD
Morphine—OPRM1—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	2.74e-05	0.00185	CbGpPWpGaD
Morphine—OPRM1—TCR Signaling Pathway—HRAS—peripheral nervous system neoplasm	2.73e-05	0.00185	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	2.72e-05	0.00184	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—COX2—peripheral nervous system neoplasm	2.69e-05	0.00182	CbGpPWpGaD
Morphine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—peripheral nervous system neoplasm	2.66e-05	0.00179	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	2.62e-05	0.00177	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—NTS—peripheral nervous system neoplasm	2.62e-05	0.00177	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—PPIP5K2—peripheral nervous system neoplasm	2.56e-05	0.00173	CbGpPWpGaD
Morphine—UGT2B15—Metabolism—GNAS—peripheral nervous system neoplasm	2.52e-05	0.0017	CbGpPWpGaD
Morphine—UGT2B4—Metabolism—GNAS—peripheral nervous system neoplasm	2.52e-05	0.0017	CbGpPWpGaD
Morphine—OPRM1—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	2.51e-05	0.0017	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—CD55—peripheral nervous system neoplasm	2.51e-05	0.00169	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—peripheral nervous system neoplasm	2.5e-05	0.00169	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—VIP—peripheral nervous system neoplasm	2.49e-05	0.00168	CbGpPWpGaD
Morphine—UGT2B15—Metabolism—ABCB1—peripheral nervous system neoplasm	2.47e-05	0.00167	CbGpPWpGaD
Morphine—UGT2B4—Metabolism—ABCB1—peripheral nervous system neoplasm	2.47e-05	0.00167	CbGpPWpGaD
Morphine—OPRM1—TCR Signaling Pathway—AKT1—peripheral nervous system neoplasm	2.41e-05	0.00163	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	2.41e-05	0.00163	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—GNS—peripheral nervous system neoplasm	2.37e-05	0.0016	CbGpPWpGaD
Morphine—ABCB1—Allograft Rejection—CASP3—peripheral nervous system neoplasm	2.32e-05	0.00157	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	2.3e-05	0.00155	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—NTS—peripheral nervous system neoplasm	2.29e-05	0.00155	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—peripheral nervous system neoplasm	2.29e-05	0.00155	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—NME1—peripheral nervous system neoplasm	2.27e-05	0.00154	CbGpPWpGaD
Morphine—ABCB1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	2.23e-05	0.00151	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—CD55—peripheral nervous system neoplasm	2.2e-05	0.00149	CbGpPWpGaD
Morphine—OPRD1—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	2.19e-05	0.00148	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—COX2—peripheral nervous system neoplasm	2.19e-05	0.00148	CbGpPWpGaD
Morphine—ABCB1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	2.14e-05	0.00145	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—PPIP5K2—peripheral nervous system neoplasm	2.1e-05	0.00142	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—ENO2—peripheral nervous system neoplasm	2.08e-05	0.0014	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	1.99e-05	0.00134	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—VIP—peripheral nervous system neoplasm	1.98e-05	0.00134	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—NTS—peripheral nervous system neoplasm	1.94e-05	0.00131	CbGpPWpGaD
Morphine—OPRK1—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	1.92e-05	0.0013	CbGpPWpGaD
Morphine—OPRD1—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	1.92e-05	0.00129	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—CD55—peripheral nervous system neoplasm	1.86e-05	0.00126	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	1.83e-05	0.00124	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—ENO2—peripheral nervous system neoplasm	1.77e-05	0.00119	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—BCHE—peripheral nervous system neoplasm	1.76e-05	0.00119	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	1.74e-05	0.00118	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	1.74e-05	0.00118	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—VIP—peripheral nervous system neoplasm	1.74e-05	0.00117	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.73e-05	0.00117	CbGpPWpGaD
Morphine—OPRL1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.7e-05	0.00115	CbGpPWpGaD
Morphine—OPRK1—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	1.68e-05	0.00114	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.68e-05	0.00113	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.67e-05	0.00113	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—TH—peripheral nervous system neoplasm	1.65e-05	0.00112	CbGpPWpGaD
Morphine—OPRM1—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	1.62e-05	0.0011	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	1.6e-05	0.00108	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	1.53e-05	0.00103	CbGpPWpGaD
Morphine—ABCB1—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.5e-05	0.00102	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—BCHE—peripheral nervous system neoplasm	1.49e-05	0.00101	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	1.47e-05	0.000997	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—VIP—peripheral nervous system neoplasm	1.47e-05	0.000993	CbGpPWpGaD
Morphine—ABCB1—HIF-1-alpha transcription factor network—AKT1—peripheral nervous system neoplasm	1.45e-05	0.000981	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—ENO2—peripheral nervous system neoplasm	1.44e-05	0.000971	CbGpPWpGaD
Morphine—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	1.44e-05	0.00097	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.43e-05	0.000963	CbGpPWpGaD
Morphine—OPRM1—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	1.42e-05	0.00096	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.42e-05	0.000958	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—TH—peripheral nervous system neoplasm	1.4e-05	0.000949	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	1.37e-05	0.000929	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.37e-05	0.000927	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	1.36e-05	0.000916	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—GNAS—peripheral nervous system neoplasm	1.35e-05	0.000911	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—ABCB1—peripheral nervous system neoplasm	1.32e-05	0.000894	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.32e-05	0.000894	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	1.29e-05	0.000871	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	1.26e-05	0.000853	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—GNS—peripheral nervous system neoplasm	1.25e-05	0.000844	CbGpPWpGaD
Morphine—OPRL1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.25e-05	0.000842	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—BCHE—peripheral nervous system neoplasm	1.21e-05	0.00082	CbGpPWpGaD
Morphine—OPRL1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.21e-05	0.000819	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	1.21e-05	0.000817	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	1.21e-05	0.000814	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.2e-05	0.000811	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—NME1—peripheral nervous system neoplasm	1.2e-05	0.000809	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.18e-05	0.000794	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.16e-05	0.000782	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—COX2—peripheral nervous system neoplasm	1.15e-05	0.000779	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—GNAS—peripheral nervous system neoplasm	1.15e-05	0.000775	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	1.15e-05	0.000774	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—TH—peripheral nervous system neoplasm	1.14e-05	0.000771	CbGpPWpGaD
Morphine—ABCB1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	1.13e-05	0.000766	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—ABCB1—peripheral nervous system neoplasm	1.13e-05	0.00076	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.12e-05	0.000757	CbGpPWpGaD
Morphine—OPRL1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.1e-05	0.000744	CbGpPWpGaD
Morphine—ABCB1—Metabolism—GNS—peripheral nervous system neoplasm	1.09e-05	0.000735	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	1.06e-05	0.000717	CbGpPWpGaD
Morphine—ABCB1—Metabolism—NME1—peripheral nervous system neoplasm	1.04e-05	0.000705	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.03e-05	0.000697	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.03e-05	0.000695	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—GNS—peripheral nervous system neoplasm	1.03e-05	0.000693	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	1.02e-05	0.000688	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.01e-05	0.00068	CbGpPWpGaD
Morphine—ABCB1—Metabolism—COX2—peripheral nervous system neoplasm	1e-05	0.000678	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—NME1—peripheral nervous system neoplasm	9.83e-06	0.000664	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	9.82e-06	0.000664	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—COX2—peripheral nervous system neoplasm	9.46e-06	0.000639	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—MYC—peripheral nervous system neoplasm	9.37e-06	0.000633	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—GNAS—peripheral nervous system neoplasm	9.32e-06	0.00063	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—HSD17B12—peripheral nervous system neoplasm	9.27e-06	0.000626	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—ABCB1—peripheral nervous system neoplasm	9.14e-06	0.000618	CbGpPWpGaD
Morphine—ABCB1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	9.13e-06	0.000617	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	9.01e-06	0.000609	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	8.96e-06	0.000606	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	8.95e-06	0.000604	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—KNG1—peripheral nervous system neoplasm	8.71e-06	0.000589	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	8.3e-06	0.000561	CbGpPWpGaD
Morphine—UGT1A8—Metabolism—AKT1—peripheral nervous system neoplasm	7.77e-06	0.000525	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—TP53—peripheral nervous system neoplasm	7.7e-06	0.00052	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	7.62e-06	0.000515	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—ENO2—peripheral nervous system neoplasm	7.56e-06	0.000511	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	7.36e-06	0.000497	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	7.35e-06	0.000496	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	7.27e-06	0.000491	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	7.14e-06	0.000483	CbGpPWpGaD
Morphine—UGT2B4—Metabolism—AKT1—peripheral nervous system neoplasm	6.79e-06	0.000459	CbGpPWpGaD
Morphine—UGT2B15—Metabolism—AKT1—peripheral nervous system neoplasm	6.79e-06	0.000459	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—GNS—peripheral nervous system neoplasm	6.7e-06	0.000453	CbGpPWpGaD
Morphine—ABCB1—Metabolism—ENO2—peripheral nervous system neoplasm	6.59e-06	0.000445	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	6.5e-06	0.000439	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—NME1—peripheral nervous system neoplasm	6.42e-06	0.000434	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—BCHE—peripheral nervous system neoplasm	6.39e-06	0.000432	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	6.38e-06	0.000431	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	6.26e-06	0.000423	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—ENO2—peripheral nervous system neoplasm	6.21e-06	0.00042	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	6.2e-06	0.000419	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—COX2—peripheral nervous system neoplasm	6.18e-06	0.000418	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—SLC2A1—peripheral nervous system neoplasm	6.1e-06	0.000412	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—TH—peripheral nervous system neoplasm	6.01e-06	0.000406	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	5.65e-06	0.000382	CbGpPWpGaD
Morphine—ABCB1—Metabolism—BCHE—peripheral nervous system neoplasm	5.57e-06	0.000376	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	5.39e-06	0.000364	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	5.32e-06	0.000359	CbGpPWpGaD
Morphine—ABCB1—Metabolism—SLC2A1—peripheral nervous system neoplasm	5.31e-06	0.000359	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	5.29e-06	0.000358	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—BCHE—peripheral nervous system neoplasm	5.25e-06	0.000355	CbGpPWpGaD
Morphine—ABCB1—Metabolism—TH—peripheral nervous system neoplasm	5.24e-06	0.000354	CbGpPWpGaD
Morphine—OPRD1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	5.17e-06	0.00035	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	5.12e-06	0.000346	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—SLC2A1—peripheral nervous system neoplasm	5.01e-06	0.000338	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	4.95e-06	0.000335	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—TH—peripheral nervous system neoplasm	4.93e-06	0.000333	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—GNAS—peripheral nervous system neoplasm	4.91e-06	0.000332	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—ABCB1—peripheral nervous system neoplasm	4.81e-06	0.000325	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	4.7e-06	0.000317	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	4.66e-06	0.000315	CbGpPWpGaD
Morphine—OPRK1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	4.54e-06	0.000306	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	4.49e-06	0.000304	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	4.3e-06	0.00029	CbGpPWpGaD
Morphine—ABCB1—Metabolism—GNAS—peripheral nervous system neoplasm	4.27e-06	0.000289	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	4.18e-06	0.000283	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	4.12e-06	0.000278	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—ENO2—peripheral nervous system neoplasm	4.06e-06	0.000274	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—GNAS—peripheral nervous system neoplasm	4.03e-06	0.000272	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—MYC—peripheral nervous system neoplasm	4e-06	0.00027	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—ABCB1—peripheral nervous system neoplasm	3.95e-06	0.000267	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	3.94e-06	0.000266	CbGpPWpGaD
Morphine—OPRM1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	3.83e-06	0.000259	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	3.8e-06	0.000257	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	3.77e-06	0.000255	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—AKT1—peripheral nervous system neoplasm	3.64e-06	0.000246	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—MYC—peripheral nervous system neoplasm	3.51e-06	0.000237	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	3.48e-06	0.000235	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—BCHE—peripheral nervous system neoplasm	3.43e-06	0.000232	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—TP53—peripheral nervous system neoplasm	3.29e-06	0.000222	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.27e-06	0.000221	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—TH—peripheral nervous system neoplasm	3.23e-06	0.000218	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	3.18e-06	0.000215	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.14e-06	0.000212	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—AKT1—peripheral nervous system neoplasm	3.09e-06	0.000209	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—MYC—peripheral nervous system neoplasm	2.97e-06	0.0002	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—TP53—peripheral nervous system neoplasm	2.88e-06	0.000195	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	2.77e-06	0.000187	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	2.76e-06	0.000186	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—GNAS—peripheral nervous system neoplasm	2.63e-06	0.000178	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—ABCB1—peripheral nervous system neoplasm	2.58e-06	0.000175	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—AKT1—peripheral nervous system neoplasm	2.51e-06	0.00017	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—TP53—peripheral nervous system neoplasm	2.43e-06	0.000165	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	2.43e-06	0.000164	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	2.33e-06	0.000157	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	2.06e-06	0.000139	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—AKT1—peripheral nervous system neoplasm	1.32e-06	8.95e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—AKT1—peripheral nervous system neoplasm	1.15e-06	7.8e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—AKT1—peripheral nervous system neoplasm	1.09e-06	7.35e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—AKT1—peripheral nervous system neoplasm	7.11e-07	4.8e-05	CbGpPWpGaD
